跳至主要内容
临床试验/NCT03953560
NCT03953560已完成不适用

Symptom-related Screening Program Following Pulmonary Embolism for Early Detection of Chronic ThromboEmbolic Pulmonary Hypertension (CTEPH)

Luis Jara-Palomares, MD16 个研究点 分布在 1 个国家目标入组 646 人开始时间: 2019年1月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
646
试验地点
16
主要终点
Number of new diagnosis of CTEPH

研究概览

简要总结

Routine screening for Chronic thromboembolic pulmonary hypertension (CTEPH) i after PE is not supported by current evidence and guidelines.

This study aims to evaluate if a screening program for patients with acute PE based on telephone monitoring of symptoms and further examination if only symptomatic patients could help an early detection of CTEPH.

详细描述

Chronic thromboembolic pulmonary hypertension (CTEPH) is a long-term complication following an acute or silent pulmonary embolism (PE). A history of acute PE was reported in 75% of CTEPH patients. Nevertheless, incidence of CTEPH after a confirmed acute PE vary widely depending of the studies, with estimated incidence from 0.5 to 4%. Performing a follow-up examination of patients diagnosed with acute PE regardless of persisting symptoms and using all available technical procedures is not cost-effective. As a consequence, routine screening for CTEPH after PE is not supported by current evidence and guidelines.

CTEPH is a very disabling and mortal disease, although it is a potential curable disease. However, delayed diagnosis and misdiagnosis is common. Patients are frequently diagnosed with CTEPH at advanced stages of the disease leading to worse clinical outcomes. Early diagnosis of CTEPH is essential, as delay in diagnosis may be associated with a worse prognosis, higher perioperative mortality and inoperable diseases stages. Overall, evidence from various sources suggests that early detection and treatment of CTEPH is advantageous in achieving favorable clinical outcomes. Therefore, there is an important unmet need for early diagnosing this disease.

Focusing diagnostic procedures only on symptomatic patients may be a practical approach for detecting relevant CTEPH.

This study aims to evaluate if a screening program for patients with acute PE based on telephone monitoring of symptoms and further examination if only symptomatic patients could help an early detection of CTEPH.

Objectives

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age > 18 year
  • •Objectively confirmed diagnosis of acute PE by multidetector CT, V/Q lung scan, or selective pulmonary angiography, according to established diagnostic criteria, with or without symptomatic DVT,
  • •Ability of subject to understand the character and consequences of the study,
  • •informed consent of the subject.

排除标准

  • •refused informed consent, inability to cooperation.

研究组 & 干预措施

Screening

Experimental

Intervention Investigator from each center will recover consecutives PE patients and collect baseline, demographic and comorbidities.

In all patients enrolled in the study a short questionnaire regarding dyspnea symptoms will be performed. All patients that refer dyspnea grade ≥ II according NYHA-WHO (6) modified scale will be cited as outpatient to be evaluated Imaging studies and right heart catheterization is the procedure agreeing with the standard care according to current ESC/ERS Guidelines.

In all patients, the following tests will be performed:

  1. Pulsioximetry.
  2. Electrocardiogram.
  3. Blood sample with determination of NT-ProBNP.
  4. Echocardiography. Only an echocardiography indicative of PH warrants further evaluation
  5. V/Q scintigraphy. Possible CTEPH can be assumed when mismatched perfusion defects are detected by VQ scan.
  6. Right heart catheterization & Pulmonary CT Scan are required for confirming the diagnosis

干预措施: dyspnea grade ≥ II according NYHA-WHO (Diagnostic Test)

结局指标

主要结局

Number of new diagnosis of CTEPH

时间窗: Up 3 years after PE

New diagnosis of CTEPH

次要结局

  • Derivation of a score to identify high risk population to develop CTEPH(Up 3 years after PE)
  • External validation from score to identify patients at risk to develop CTEPH(Up 3 years after PE)
  • Number of patients with Chronic Thromboembolic Disease (CTED) after PE(Up 3 years after PE)

研究者

发起方
Luis Jara-Palomares, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Luis Jara-Palomares, MD

Principal Investigator

Hospitales Universitarios Virgen del Rocío

研究点 (16)

Loading locations...

相似试验